AVNS vs. ZJYL, ESTA, SMTI, ENOV, PRAX, RLAY, ETNB, OPK, IMTX, and MESO
Should you be buying Avanos Medical stock or one of its competitors? The main competitors of Avanos Medical include Jin Medical International (ZJYL), Establishment Labs (ESTA), Sanara MedTech (SMTI), Enovis (ENOV), Praxis Precision Medicines (PRAX), Relay Therapeutics (RLAY), 89bio (ETNB), OPKO Health (OPK), Immatics (IMTX), and Mesoblast (MESO). These companies are all part of the "medical" sector.
Avanos Medical (NYSE:AVNS) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, community ranking, analyst recommendations, media sentiment, profitability, institutional ownership and risk.
In the previous week, Avanos Medical had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for Avanos Medical and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 1.89 beat Avanos Medical's score of 0.53 indicating that Jin Medical International is being referred to more favorably in the news media.
Avanos Medical received 83 more outperform votes than Jin Medical International when rated by MarketBeat users.
Avanos Medical has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 18.8, indicating that its share price is 1,780% more volatile than the S&P 500.
Jin Medical International has lower revenue, but higher earnings than Avanos Medical.
Avanos Medical presently has a consensus price target of $31.00, suggesting a potential upside of 54.46%. Given Avanos Medical's higher probable upside, analysts plainly believe Avanos Medical is more favorable than Jin Medical International.
Jin Medical International has a net margin of 0.00% compared to Avanos Medical's net margin of -9.15%. Avanos Medical's return on equity of 4.10% beat Jin Medical International's return on equity.
95.2% of Avanos Medical shares are owned by institutional investors. 3.9% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Avanos Medical beats Jin Medical International on 9 of the 12 factors compared between the two stocks.
Get Avanos Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Avanos Medical Competitors List
Related Companies and Tools
